Classement en actions
#10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Prix de l'action
$19.81
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$891.32M
Changement (1 jour)
1.39%
Échange Beta Bionics, Inc. (BBNX)
Le prix BBNX avec la capitalisation boursière de B
Capitalisation boursière de Beta Bionics, Inc.(BBNX)
Capitalisation boursière: $891.32M
En August 2026, Beta Bionics, Inc. a une capitalisation boursière de $891.32M. Cela fait de Beta Bionics, Inc. la 10096th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Beta Bionics, Inc. du 2025 au 2026
BBNX par rapport au top 5 des plus populaires stocks
| Prix pour BBNX |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.264T
|
+590,468.44%
|
|
|
|
|
$4.701T
|
+527,349.64%
|
|
|
|
|
$4.177T
|
+468,549.57%
|
|
|
|
|
$3.817T
|
+428,185.19%
|
|
|
|
|
$2.866T
|
+321,482.56%
|
